Cargando…
Class I HDAC Inhibitor Improves Synaptic Proteins and Repairs Cytoskeleton Through Regulating Synapse-Related Genes In vitro and In vivo
β-amyloid (Aβ) is an important protein molecule in the pathology of Alzheimer’s disease (AD). Accumulation of Aβ leads to the loss of dendritic spines and synapses. These impairments can be ameliorated by histone deacetylase inhibitors (HDACI). However, the mechanisms of HDACIs underlying the effect...
Autores principales: | Han, Ying, Chen, Le, Guo, Yu, Wang, Chunyang, Zhang, Chenghong, Kong, Li, Ma, Haiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852506/ https://www.ncbi.nlm.nih.gov/pubmed/33542682 http://dx.doi.org/10.3389/fnagi.2020.619866 |
Ejemplares similares
-
A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway
por: Han, Ying, et al.
Publicado: (2022) -
Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice
por: Wang, Chunyang, et al.
Publicado: (2023) -
A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca(2+) Signaling Pathway
por: Liu, Jingyun, et al.
Publicado: (2022) -
In vivo proximity proteomics of nascent synapses reveals a novel regulator of cytoskeleton-mediated synaptic maturation
por: Spence, Erin F., et al.
Publicado: (2019) -
Turnover of Synapse and Dynamic Nature of Synaptic Molecules In Vitro and In Vivo
por: Kondo, Satoru, et al.
Publicado: (2011)